Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum

Ítems similars

• Evaluation of molecular forms of PSA and human kallikrein 2 in predicting biochemical failure following radical prostatectomy
  per: Wenske, Sven, et al.
  Publicat: (2009)
• Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.
  per: Piironen, T., et al.
  Publicat: (1998)
• A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
  per: Haese, Alexander, et al.
  Publicat: (2020)
• Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy
  per: O'Brien, Matthew Frank, et al.
  Publicat: (2009)
• Simultaneous Quantification of Human Glandular Kallikrein 2 and Prostate-Specific Antigen mRNAs in Peripheral Blood from Prostate Cancer Patients
  per: Ylikoski, Alice, et al.
  Publicat: (2001)